# Transcriptomic Study of ER 4017 Topical Application in Elderly Subject

> **NCT00818545** · NA · COMPLETED · sponsor: **L'Oreal** · enrollment: 10 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** ER4017 (hydroxypropyltetrahydropyrantriol)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00818545
- **Lead sponsor:** L'Oreal
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2009-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818545, "Transcriptomic Study of ER 4017 Topical Application in Elderly Subject". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00818545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*